Participants

Invited Experts^h

Dr Bilali Camara
Caribbean Epidemiology Centre
Port-of-Spain, Trinidad and Tobago

Dr FranHois Clavel
IMEA/INSERM
Paris, France

Dr Anna Coutsoudis
University of Natal
Durban, South Africa

Dr Isabelle de Vincenzi (Rapporteur)
Cercier,
France

Dr Brooks Jackson
Johns Hopkins University
Baltimore, United States of America

Dr Siripon Kanshana
Ministry of Public Health
Bangkok, Thailand

Dr Charles Karamagi
Makere University
Kampala, Uganda

Dr David A. Katzenstein
Stanford University Medical Center
Stanford, United States of America

Dr James N. Kiarie
Kenyatta National Hospital
Nairobi, Kenya

Dr Elizabeth Madraa
Ministry of Health
Kampala, Uganda

Dr Augustine Massawe
Muhimbili Medical Centre
Dar-es-Salaam, Tanzania

Dr James McIntyre
Chris Hani Baragwanath Hospital
Johannesburg, South Africa

Dr Stephen Munjanja
University of Zimbabwe
Harare, Zimbabwe

Dr Rafael N<jera
Instituto de Salud Carlos III
Madrid, Spain

Dr Marie-Louise Newell
Institute of Child Health
London, United Kingdom

Miss Florence Ngobeni
Chris Hani Baragwanath Hospital
Johannesburg, South Africa

Dr Innocent Ntaganira
Rwanda AIDS Control Programme
Kigali, Rwanda

Dr Marina Rea
Instituto de Saude
Sao Paulo, Brazil

Dr Nigel Rollins
University of Natal
Durban, South Africa

Dr Subhash Salunke
Maharasthra State Health Service
Mumbai, India

Dr Moses Sichone
National HIV/AIDS Council
Lusaka, Zambia

Dr Nono Simelela
HIV/AIDS and STD Programme
Pretoria, South Africa

Dr Beatrice N. Were
NACWOLA
Kampala, Uganda

^h The following experts declared financial or other interests related to the subject matter of the consultation:

· Dr Brooks Jackson has received travel, speaker/consultant fees from Boehringer-Ingelheim.

· Dr David Katzenstein has received research grants and speaker/consultant fees from Roche, DuPont, Bristol-Myers Squibb, and Glaxo Wellcome, and holds stock in Merck.

· Dr James McIntyre’s institution has received research funds from Glaxo Wellcome, Bristol-Myers Squibb and Boehringer-Ingelheim. He has received speaker fees from Glaxo Wellcome and wrote an expert report for Boehringer-Ingelheim.

Collaborating Agencies

Dr FranHois Dabis
ANRS/INSERM U.330
Bordeaux, France

Dr Kevin De Cock (Chair)
Centers for Disease Control
Nairobi, Kenya

Dr Mary Glenn Fowler
Centers for Disease Control
Atlanta, United States of America

Dr Paolo G. Miotti
NIAID, National Institute of Health
Bethesda, United States of America

Dr Lynne M. Mofenson
National Institutes of Health
United States of America

Dr Ellen G. Piwoz
Academy for Educational Development
Rockville, United States of America

Dr David Stanton
USAID
Washington, United States of America

Dr Eric Van Praag
Family Health International
Arlington, United States of America

Observers

Dr Marie Ahouanto
Fonds de Solidarithpeutique International
Paris, France

Dr Geert Haverkamp
International Antiviral Therapy Evaluation
Amsterdam, The Netherlands

Dr John Mbambo
Ministry of Health and Social Welfare
Swaziland

Dr Nathan Shaffer
CDC LIFE Program
Atlanta, United States of America

Mrs Thuli Sibiya
Ministry of Health and Social Welfare
Swaziland

Dr Elisabeth Szumilin
Mcins sans Frontis
Paris, France

Professor Catherine M. Wilfert
Elisabeth Glaser Pediatric AIDS Foundation
Durham, United States of America

UN Agencies and UNAIDS

UNAIDS

UNAIDS, Geneva, Switzerland
Dr Justin Mandala
Dr David Miller
Dr Jos Perri

UNAIDS, Abidjan, Cd’Ivoire
Dr Touissant Sibailly

UNAIDS, Addis Ababa, Ethiopia
Dr Connie Osborn

UNFPA

UNFPA, Geneva, Switzerland
Dr Hans de Knocke

UNICEF

UNICEF New York, United States of America
Dr David J. Alnwick
Dr Eric Mercier
Dr Eric Mouzin
Dr Gay Palmer

UNICEF ESARO, Nairobi, Kenya
Dr Arjan de Wagt
Dr Olivia Yambi

UNICEF, Harare, Zimbabwe
Dr Peggy Henderson

World Health Organization

WHO, Geneva, Switzerland

Dr David Nabarro, DGO
Dr Tomris T DGO
Dr Winnie Mpanju-Shumbusho, FCH/HSI
Dr Catherine d’Arcangues, RHR/RAE
Dr Graham Clugston, SDE/NHD
Ms FadJla Chatb, ECP/SPO
Pr. Suzanne Garland, RHR/FCH
Dr Hans Hogerzeil, EDM/PAR
Dr Paula Munderi, FCH/HSI
Mrs Randa Saadeh, SDE/NHD
Dr Constanza Vallenas, FCH/CAH

WHO AFRO, Harare, Zimbabwe
Ms Elizabeth Hoff
Dr Francis Onyango
Dr Elizabeth Mason

WHO EURO, Copenhagen, Denmark
Dr Birgit Lunden

Consultation Secretariat

WHO, Geneva, Switzerland

Dr Timothy Farley, RHR/RAEⁱ
Dr Dirk Buyse, RHR/RAE
Dr Philippe Gaillard, RHR/RAE
Mrs Christine Gray, RHR/RAE
Dr Isabelle de Zoysa, FCH/HSI
Dr Felicity Savage-King, FCH/CAH

ⁱ Contact address:

Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland. Tel: +41 22 791 33 10, Fax: +41 22 791 41 71, email: FarleyT@who.int